NIH-funded research R01 grant

Understanding how Epstein-Barr Virus may trigger multiple sclerosis

Official title: Deciphering the Role of Epstein-Barr Virus Molecular Mimicry and B cell Transformation in Multiple Sclerosis

Funded at Stanford University · NIH-10997373 · Data updated 2026-11-12

This study is looking at how the Epstein-Barr Virus might play a role in causing multiple sclerosis by changing certain immune cells, and it's for anyone interested in understanding more about how MS develops and progresses.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startJanuary 3, 2023
Project endDecember 31, 2027
Funding year2025
Award (this year)$570,031
NIH project number5R01AI173189-03
Project IDNIH-10997373 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with multiple sclerosis who have a history of Epstein-Barr Virus infection.

Less likely to help

Patients who do not have multiple sclerosis or have not been infected with Epstein-Barr Virus may not benefit from this research.

What this research studies

This research investigates the connection between Epstein-Barr Virus (EBV) infection and the development of multiple sclerosis (MS). It focuses on how EBV may transform B cells in patients, leading to the activation of autoreactive T cells and the production of autoantibodies that contribute to MS pathology. The study will analyze the genetic and molecular mechanisms involved, aiming to identify specific disease subtypes associated with different immune responses. By examining these processes, the research seeks to uncover critical insights into MS development and progression.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for preventing or treating multiple sclerosis.

How similar studies have gone: Previous research has shown a strong correlation between Epstein-Barr Virus infection and multiple sclerosis, indicating that this approach is grounded in established findings.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Robinson, William H — Stanford University
  • Study coordinator: Robinson, William H

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.